Komori
Iwatani (8088) · InitiativeAdvanced

Gas applications and cell preservation and transport technologies in the regenerative medicine field

First written in FY2020. 3 of 4 entries say "Advanced", first in FY2021. Latest entry: FY2024.

4entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2020AdvancedFY2021 – FY20242020: 120202021: 120212022: 120222023: 020232024: 12024
Same theme, other companies
Development of gas-based cell cryopreservation and transport technology for regenerative medicineA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2024AdvancedAnnual report

    「Using the cleanroom dedicated to biological research at the Central Research Institute, our regenerative medicine and biotechnology R&D center, we confirmed that artificial blood vessels could be frozen and thawed. We will continue considering commercialization with our joint research partners.」

    In regenerative medicine, the company confirmed the freezing and thawing of artificial blood vessels and progressed to considering commercialization with its joint research partners.
  2. FY2022AdvancedAnnual report

    「We also established a cleanroom dedicated to biological research within the Central Research Institute, installed cell culture and cryopreservation equipment, and developed the research and development infrastructure as a regenerative medicine and biotechnology R&D center.」

    In regenerative medicine, a cleanroom, cell culture equipment and cryopreservation equipment were established within the Central Research Institute, creating an R&D center.
  3. FY2021AdvancedAnnual report

    「In regenerative medicine, we advanced research into optimizing cell freezing and thawing processes through joint research with universities and collaboration with partner companies, and began developing a container system for cell storage and transport.」

    In regenerative medicine, the initiative progressed from optimizing cell freezing and thawing processes to starting development of a container system for cell storage and transport.
  4. FY2020First statedAnnual report

    「In regenerative medicine, we promoted the development of gas applications for cell preservation and cell storage and transport technologies in collaboration with university research institutions.」

    Through joint research with university research institutions, the company is advancing gas applications for cell preservation and the development of cell storage and transport technologies.
Moved together

"Realizing a Hydrogen Energy Society" moved the same way as this thread, in the same document, in 3 of its 4 moves.

333333★123456
  1. ★This thread
  2. 1Realizing a Hydrogen Energy Society3×
  3. 2Building a Liquefied Hydrogen Supply Chain3×
  4. 3Expansion of integrated energy and lifestyle services3×
  5. 4Open research and development centered on the Central Research Institute3×
  6. 5Shareholdings Held to Build, Maintain and Strengthen Business Relationships3×
  7. 6Japan’s first commercial production and sale of deuterium gas3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Iwatani's next results are scheduled for 2026-11-10. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.